Page 48 - Viewray Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article CLEVELAND, May 25, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that American Hospital in Istanbul, Turkey, has purchased a MRIdian MRI-guided radiation therapy system to expand their radiotherapy and stereotactic body radiation therapy (SBRT) programs. The MD Anderson Radiation Treatment Center at the American Hospital offers world-class, cutting-edge technology to facilitate customized approaches to each patient's diagnosis and treatment. The addition of MRIdian further supports American Hospital's mission by enabling personalized...

Operator Welcome to the Q1 2021 ViewRay Incorporated earnings conference call. My name is Darryl and I'll be your operator for today's call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator instructions] I will now turn the call over to Ashley Kluth. Ashley, you may begin. Ashley Kluth -- Senior Manager, Investor Relations Thank you, operator. Good afternoon, everyone, and welcome to ViewRay's first-quarter 2021 financial results conference call. Joining me today are Scott Drake, our president and chief executive officer...

ViewRay Reports First Quarter 2021 Results News provided by Share this article CLEVELAND, May 6, 2021 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights Received seven new orders for MRIdian systems totaling $40.9 million, compared to four new orders totaling $22.6 million in the first quarter of 2020. Total backlog increased to $264.3 million as of March 31, 2021, compared to $230.8 million as of March 31, 2020. Total revenue of $15.5 million primarily from two revenue u...

Share this article SAN FRANCISCO, April 19, 2021 /PRNewswire/ -- The global radiation oncology market size is expected to reach USD 11.7 billion by 2028, registering a CAGR of 7.0% over the forecast period, according to a new report by Grand View Research, Inc. The rising incidence of cancer and technological advancement in radiation therapy equipment are some of the major factors driving the growth of the market. Key suggestions from the report: Due to the high availability of External Beam Radiation Therapy (EBRT) equipment and penetration of innovative diagnostic instruments and underst...

ViewRay Announces Departure of Chief Operating Officer News provided by Share this article Share this article CLEVELAND, March 15, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced that Shahriar Matin, Chief Operating Officer, will leave the Company effective March 31, 2021. Matin was named Chief Executive Officer designate of Cordis in its recently announced divestiture from Cardinal Health to private equity firm Hellman & Friedman. "It has been a privilege to work alongside the ViewRay team, and I believe that MRIdian is unequivocally the future of radiation ...